Home › NDC Lookup › RxCUI directory › RxCUI 208969

Pralidoxime chloride 1000 MG Injection [Protopam] — RxCUI 208969

RxNorm drug concept · Semantic branded drug
RxCUI 208969 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI208969
Official namePralidoxime chloride 1000 MG Injection [Protopam]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asProtopam 1 GM Injection; Protopam Chloride 1 GM Injection; Protopam 1000 MG Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How Pralidoxime chloride 1000 MG Injection [Protopam... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pralidoxime chloride 1000 MG Injection [Protopam] RxCUI 208969

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Pralidoxime 34345
    • Pralidoxime chloride 55322
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Protopam 1486892
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pralidoxime Injection 1663396
    • Pralidoxime chloride Injection 2649321
    • Pralidoxime Injectable Product 1165733
    • Pralidoxime chloride Injectable Product 2661047
    • Pralidoxime Injection [Protopam] 1663399
    • Pralidoxime chloride Injection [Protopam] 2656949
    • Protopam Injectable Product 1182457
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pralidoxime chloride 1000 MG Injection SCD · 312576
  • Pralidoxime chloride 1000 MG SCDC · 1663395
  • Pralidoxime Injection SCDF · 1663396
  • Pralidoxime chloride Injection SCDFP · 2649321
  • Pralidoxime Injectable Product SCDG · 1165733
  • Pralidoxime chloride Injectable Product SCDGP · 2661047

Brand-Name Concepts

  • Pralidoxime chloride 1000 MG [Protopam] SBDC · 1663398
  • Pralidoxime Injection [Protopam] SBDF · 1663399
  • Pralidoxime chloride Injection [Protopam] SBDFP · 2656949
  • Protopam Injectable Product SBDG · 1182457
  • Protopam BN · 1486892

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 208969 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
60977-0141-01 6 VIAL, SINGLE-DOSE in 1 PACKAGE (60977-141-01) / 20 mL in... Protopam Chloride Baxter Healthcare Corporation 1965-03-10
Observed labelers: Baxter Healthcare Corporation (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.